Q5115 – Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
HCPCS Level II code · Q codes: Temporary Codes
HCPCS codeQ5115
- Long description
- Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
- Short description
- Inj truxima 10 mg
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- Added
- July 1, 2019
- Last change
- July 1, 2019 – No change
Frequently asked questions
What is HCPCS code Q5115?
Q5115 is a HCPCS Level II code for injection, rituximab-abbs, biosimilar, (truxima), 10 mg.
Does Medicare cover Q5115?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby Q codes
- Q5107 – Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
- Q5108 – Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
- Q5109 – Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
- Q5110 – Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
- Q5111 – Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
- Q5112 – Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
- Q5113 – Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
- Q5114 – Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg
- Q5116 – Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
- Q5117 – Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
- Q5118 – Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
- Q5119 – Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg
- Q5120 – Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg
- Q5121 – Injection, infliximab-axxq, biosimilar, (avsola), 10 mg
- Q5122 – Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
- Q5123 – Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.